Tuesday, October 19 2021

Here is a summary of the current health briefs.

Henrietta Lacks estate claims drug company took advantage of stolen cells

The estate of a black woman whose cervical cells were taken from her decades ago without her permission sued a pharmaceutical company on Monday, claiming she made a “conscious choice” to mass produce the cells and profit. of a “racially unjust medical system”. The estate of Henrietta Lacks did not “see a dime” of the income Thermo Fisher Scientific generated by cultivating the HeLa cell line that was taken from Lacks at Johns Hopkins Hospital in 1951, according to the lawsuit filed before the Maryland Federal Court.

J&J to seek US FDA clearance for booster injection this week – NYT

Johnson & Johnson plans to ask U.S. federal regulators this week to authorize a booster of its COVID-19 vaccine, The New York Times reported on Monday, citing officials familiar with the company’s plans. As scientists are divided over the need for booster vaccines as so many people in the United States and other countries go unvaccinated, the Biden administration announced the push for an additional dose in August as part of the an effort to strengthen protection against the highly transmissible delta. variant.

Drugstore chains failed to prevent opioid abuse, US jury says

Drugstore operators, including CVS Health Corp and Walmart Inc, have fueled the opioid epidemic in the United States by failing to prevent massive amounts of addictive pain relievers from reaching the black market, an attorney for the United States said Monday. two Ohio counties at the start of a lawsuit. Mark Lanier told a federal jury in Cleveland during the hearing of the first trial that drugstore chains faced in a nationwide litigation over the epidemic that companies were responsible for drug abuse in the counties of Lake and Trumbull.

Pfizer / BioNTech COVID-19 vaccine efficacy drops after 6 months – study

The effectiveness of the Pfizer Inc / BioNTech SE vaccine in preventing coronavirus infection fell to 47% from 88% six months after the second dose, according to data released Monday that U.S. health agencies considered when they have decided on the need for booster vaccines. The data, which was published in the medical journal published by Lancet, had already been published in August ahead of the peer review.

Australia buys COVID-19 pill from Merck, Victoria cases hit record

Australia will buy 300,000 courses of the experimental antiviral pill from Merck & Co, Prime Minister Scott Morrison said on Tuesday, as Victoria recorded the highest number of daily COVID-19 infections of any state in the country since the start of the pandemic. Molnupiravir, which would be the first oral antiviral drug for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19 , according to experts.

Former FDA chief Gottlieb expects Delta to be the last great pandemic wave in the United States

The summer spike in cases fueled by the Delta variant of the coronavirus is likely the last big wave of COVID-19 in the United States, but the pandemic is far from over globally, the former commissioner of the United States Food and Drug Administration, Scott Gottlieb. “I think this Delta wave is probably the last major wave of SARS-CoV-2 infection that we have in the United States, unless something unexpected happens,” Gottlieb, author of “Uncontroled” Spread, “a new book on the US response to the pandemic, said in an interview.

New York’s largest healthcare provider lays off 1,400 unvaccinated workers

New York state’s largest health care provider Northwell Health has laid off 1,400 employees who refused to be vaccinated against COVID-19, according to spokesperson Joe Kemp. As with other healthcare companies that have recently fired workers for failing to meet vaccine mandates, laid-off employees make up a small percentage of Northwell’s workforce of over 76,000, who are now all vaccinated.

Exclusive-Eli Lilly’s recalled emergency diabetes drug comes from plant cited by FDA

A recently recalled batch of Glucagon Emergency Kits, Eli Lilly and Co’s Therapy for Diabetic Patients in Crisis was manufactured at a plant in Indiana cited by U.S. health regulators this year for violations of the quality control, including several involving this product, according to the company and a Reuters review of federal inspection records. The Indianapolis-based company on September 24 issued a voluntary recall in the United States of a batch of kits whose key ingredient is Glucagon, a drug used to treat dangerously low blood sugar in diabetic patients. The company issued a voluntary recall in Canada the next day.

Two Americans win Nobel Prize in medicine for their work on heat and touch

US scientists David Julius and Ardem Patapoutian won the 2021 Nobel Prize in Medicine on Monday for the discovery of receptors in the skin that sense temperature and touch and could pave the way for new pain relievers. Their work, conducted independently, has helped show how humans convert the physical impact of heat or touch into nerve impulses that allow us to “perceive and adapt to the world around us,” said L Nobel Assembly of the Karolinska Institute in Sweden.

New Zealand to use vaccination certificates as Delta persists

New Zealand said on Tuesday it would start using COVID-19 vaccine certificates as proof of inoculation during large events and other high-risk settings from next month as the country battles the spread of the Delta variant. Prime Minister Jacinda Ardern, who on Monday abandoned a long-standing coronavirus elimination strategy in the face of a persistent Delta outbreak, said the certificates would help ensure that large gatherings such as music festivals do not become large-scale events.

(This story was not edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


Source link

Previous

Henrietta Lacks estate sues pharmaceutical company Thermo Fisher Scientific for selling its HeLa cells without consent

Next

A Comprehensive Assessment of Distance Pharmacy Education Amid COVID-19: Teaching, Assessment and Experiential Training

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also